Monotherapy Trials 単剤療法試験の紹介

Discover more insights into Monotherapy Trials 単剤療法試験

Keywords frequently search together with Monotherapy Trials 単剤療法試験

Narrow sentence examples with built-in keyword filters

More Monotherapy Trials 単剤療法試験 sentence examples

10.1001/jamadermatol.2019.3617

Patients with moderate to severe AD who received dupilumab treatment and achieved an Investigator's Global Assessment score of 0 or 1 or 75% improvement in Eczema Area and Severity Index scores (EASI-75) at week 16 in 2 previous dupilumab monotherapy trials (LIBERTY AD SOLO 1 and 2) were rerandomized in SOLO-CONTINUE.

デュピルマブ治療を受け、以前の2つのデュピルマブ単剤療法試験（LIBERTY AD SOLO 1および2）はSOLO-CONTINUEで再ランダム化されました。

Full Text

More Monotherapy Trials 単剤療法試験 sentence examples

10.1093/annonc/mdz253.103

Within ICI monotherapy trials, these associations were r = 0.

ICI単剤療法試験では、これらの関連はr=0でした。

Full Text

Learn more from Monotherapy Trials 単剤療法試験

Keywords related to Monotherapy

Monotherapy Treatment Monotherapy Vs Monotherapy Versus Monotherapy Failure Explore More

Keywords related to Trials

Monotherapy Trials 単剤療法試験の概要

Monotherapy Trials 単剤療法試験

Encyclopedia 百科事典

Sep 10, 2024

単剤療法試験とは何ですか？

Monotherapy Trials 単剤療法試験 - Patients with moderate to severe AD who received dupilumab treatment and achieved an Investigator's Global Assessment score of 0 or 1 or 75% improvement in Eczema Area and Severity Index scores (EASI-75) at week 16 in 2 previous dupilumab monotherapy trials (LIBERTY AD SOLO 1 and 2) were rerandomized in SOLO-CONTINUE. ^[1] Within ICI monotherapy trials, these associations were r = 0. ^[2]
デュピルマブ治療を受け、以前の2つのデュピルマブ単剤療法試験（LIBERTY AD SOLO 1および2）はSOLO-CONTINUEで再ランダム化されました。 ^[1] ICI単剤療法試験では、これらの関連はr=0でした。 ^[2]